CMHC Faculty Members

Faculty of Tarsus Medical Group are leaders in healthcare

Alan R. Saltiel, PhD

La Jolla, California

Alan R. Saltiel, PhD



Dr. Alan R. Saltiel studies the molecular and cellular biology of insulin growth and action. He has directed drug discovery activities in diabetes, obesity, and cancer, having led preclinical studies on the first thiazolidinedione approved for the treatment of type 2 diabetes, troglitazone. He also developed the first MEK inhibitors for the treatment of cancer, which received the U.S. Food and Drug Administration approval for melanoma and other cancers. He has given many named lectures and organized numerous meetings and conferences, and served on a number of advisory panels, scientific and editorial boards. He has 19 issued patents and has published over 290 original papers.

Education and Training

  • Postdoctoral Research Training in Mechanisms of Insulin Action, Wellcome Research Laboratories, 1984
  • PhD in Biochemistry, University of North Carolina, 1980
  • Bachelor Degree in Zoology, Duke University, 1975

Professional Highlights

  • Founder and Director, Institute for Diabetes and Metabolic Health, University of California San Diego 2015
  • Founding Director and John Jacob Abel Professor, Life Sciences Institute, 2001
  • Distinguished Research Fellow and Senior Director of Cell Biology, Parke Davis Pharmaceutical Research, 1990
  • Rosalyn Yalow Research and Development Award, American Diabetes Association
  • Elected Fellow, American Association for the Advancement of Science
  • Elected Member, American Society of Clinical Investigation
  • Elected Member, Institute of Medicine of National Academy of Medicine


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.